United Therapeutics Corporation

(UTHR) Trade

By |

Profile

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The firm is a market leader in two of the three primary drugs classes used to treat PAH. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug.

Contact Information

Website: www.unither.com
Email: ir@unither.com
Main Phone: +1 301 608-9292
Address: 1040 Spring Street
State: MD
City / Town: Silver Spring
Country: USA
Postal Code: 20910

Issuer Information

Exchange: NGS
CEO: Martine A. Rothblatt
Employees: 860
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The firm is a market leader in two of the three primary drugs classes used to treat PAH. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug.

Contact Information

Website: www.unither.com
Email: ir@unither.com
Main Phone: +1 301 608-9292
Address: 1040 Spring Street
State: MD
City / Town: Silver Spring
Country: USA
Postal Code: 20910

Issuer Information

Exchange: NGS
CEO: Martine A. Rothblatt
Employees: 860
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 78.23 $ -2.84 (-3.50%)
Last Price 78.23 Change $ -2.84 Change % -3.50 Tick N/A
Bid 76.10 Bid Size 100.00 Ask 82.25 Ask Size 100.00
Open 80.83 High 80.84 Low 77.78 Prev Close 81.07
Last Trade Volume 829,041 52 Wk Hi 130.00 52 Wk Low 77.78
Market Cap 3.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 43,810,915.00 EPS (TTM) -3.44 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 65 264
Number of Buys 19 114
Number of Sells 46 150
Net Activity 0 30632
Last 10 Buys Shares
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Last 10 Sell Shares
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
Martine A. Rothblatt 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 234 234 234 234
Low Target Price Estimate 95 95 95 95
Mean Target Price Estimate 126.38 126.38 128 126.38
Standard Deviation 48.36 48.36 47.83 48.36
Date of Most Recent Estimate 05/24/18 05/24/18 05/14/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 4 4 4 5
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.88 2.88 2.88 2.89